Oxidized-LDL/β2-Glycoprotein I Complexes Are Associated With Disease Severity and Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndromes-Reference-Cited by-同舟云学术

Oxidized-LDL/β2-Glycoprotein I Complexes Are Associated With Disease Severity and Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndromes

Published:2010-05 Issue:5 Volume:133 Page:737-743
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Greco Thomas P.,Conti-Kelly Ann Marie,Anthony J. Robert,Greco Thomas,Doyle Robin,Boisen Matt,Kojima Kazuo,Matsuura Eiji,Lopez Luis R.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/133/5/737/4990429/ajcpath133-0737.pdf

Reference38 articles.

1. Atherosclerosis — An Inflammatory Disease

2. Libby P Ridker PM Maseri A . Inflammation and atherosclerosis. Circulation. 2002;105:1153–1143.

3. Lindahl B Toss H Siegbahn B Markers of myocardial damage and inflammation in relation to long-term morbidity and unstable coronary heart disease. N Engl J Med. 2001;343:1139–1147.

4. Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease

5. An Assessment of Incremental Coronary Risk Prediction Using C-Reactive Protein and Other Novel Risk Markers

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sexual dimorphism in atherosclerotic plaques of aged Ldlr−/− mice;Immunity & Ageing;2024-05-02

2. Treatment of Cardiovascular Disease in Rheumatoid Arthritis: A Complex Challenge with Increased Atherosclerotic Risk;Pharmaceuticals;2021-12-22

3. Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy;The Journal of Rheumatology;2020-12-15

4. Recent Advances in the Molecular Imaging of Atherosclerosis;Seminars in Thrombosis and Hemostasis;2020-06-30

5. Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes;Endocrine, Metabolic & Immune Disorders - Drug Targets;2020-01-07